164 related articles for article (PubMed ID: 25911330)
1. The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.
Klempner SJ; Ou SH; Costa DB; VanderLaan PA; Sanford EM; Schrock A; Gay L; Ali SM; Miller VA
Clin Lung Cancer; 2015 Sep; 16(5):334-339.e1. PubMed ID: 25911330
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
[TBL] [Abstract][Full Text] [Related]
3. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.
Girard N; Ostrovnaya I; Lau C; Park B; Ladanyi M; Finley D; Deshpande C; Rusch V; Orlow I; Travis WD; Pao W; Begg CB
Clin Cancer Res; 2009 Aug; 15(16):5184-90. PubMed ID: 19671847
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.
Girard N; Deshpande C; Lau C; Finley D; Rusch V; Pao W; Travis WD
Am J Surg Pathol; 2009 Dec; 33(12):1752-64. PubMed ID: 19773638
[TBL] [Abstract][Full Text] [Related]
5. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
[TBL] [Abstract][Full Text] [Related]
6. Synchronous non-small cell lung cancers: diagnostic yield can be improved by histologic and genetic methods.
Zhang Y; Hu H; Wang R; Ye T; Pan Y; Wang L; Zhang Y; Li H; Li Y; Shen L; Yu Y; Sun Y; Chen H; Garfield D
Ann Surg Oncol; 2014 Dec; 21(13):4369-74. PubMed ID: 25081337
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular analysis of synchronous double lung cancers.
Arai J; Tsuchiya T; Oikawa M; Mochinaga K; Hayashi T; Yoshiura K; Tsukamoto K; Yamasaki N; Matsumoto K; Miyazaki T; Nagayasu T
Lung Cancer; 2012 Aug; 77(2):281-7. PubMed ID: 22560922
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.
Vignot S; Frampton GM; Soria JC; Yelensky R; Commo F; Brambilla C; Palmer G; Moro-Sibilot D; Ross JS; Cronin MT; André F; Stephens PJ; Lazar V; Miller VA; Brambilla E
J Clin Oncol; 2013 Jun; 31(17):2167-72. PubMed ID: 23630207
[TBL] [Abstract][Full Text] [Related]
9. Pathologic Staging and Survival of Patients With Synchronous Bilateral Lung Carcinomas.
Walts AE; Mirocha JM; Leong T; Marchevsky AM
Am J Clin Pathol; 2016 Feb; 145(2):244-50. PubMed ID: 26796494
[TBL] [Abstract][Full Text] [Related]
10. Multiple primary lung cancer: A literature review.
Romaszko AM; Doboszyńska A
Adv Clin Exp Med; 2018 May; 27(5):725-730. PubMed ID: 29790681
[TBL] [Abstract][Full Text] [Related]
11. Synchronous lung cancers defined by deoxyribonucleic acid flow cytometry.
Ichinose Y; Hara N; Ohta M
J Thorac Cardiovasc Surg; 1991 Sep; 102(3):418-24. PubMed ID: 1652669
[TBL] [Abstract][Full Text] [Related]
12. Histopathological and molecular study for synchronous lung adenocarcinoma staging.
Donfrancesco E; Yvorel V; Casteillo F; Stachowicz ML; Patoir A; Tiffet O; Péoc'h M; Forest F
Virchows Arch; 2020 Jun; 476(6):835-842. PubMed ID: 31900636
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
[TBL] [Abstract][Full Text] [Related]
14. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
Rafael OC; Lazzaro R; Hasanovic A
Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
[TBL] [Abstract][Full Text] [Related]
15. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer.
Murphy SJ; Aubry MC; Harris FR; Halling GC; Johnson SH; Terra S; Drucker TM; Asiedu MK; Kipp BR; Yi ES; Peikert T; Yang P; Vasmatzis G; Wigle DA
J Clin Oncol; 2014 Dec; 32(36):4050-8. PubMed ID: 25385739
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genomic profiling aids in understanding the lesion origins of a patient with six synchronous invasive lung adenocarcinomas: a case study.
Song Y; Jia Z; Wu P; Wang W; Ou Q; Bao H; Yu M; Wu X; Liu P; Liang N; Zhang S; Li S
BMC Pulm Med; 2020 Apr; 20(1):80. PubMed ID: 32245453
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
[TBL] [Abstract][Full Text] [Related]
18. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
Tomaszek SC; Huebner M; Wigle DA
Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
[TBL] [Abstract][Full Text] [Related]
19. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
Shen KR; Meyers BF; Larner JM; Jones DR;
Chest; 2007 Sep; 132(3 Suppl):290S-305S. PubMed ID: 17873175
[TBL] [Abstract][Full Text] [Related]
20. Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma.
Eguren-Santamaria I; Sanchez-Bayona R; Patiño-Garcia A; Gil-Bazo I; Lopez-Picazo JM
Lung Cancer; 2018 Aug; 122():120-123. PubMed ID: 30032819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
